Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen

AIDS

Volumn 12, Issue 11, 1998, Pages 1309-1315

  Burman, William J ^a,b   Stone, Barbara L ^a   Rietmeijer, Cornelis A ^a,b   Maslow, Joel ^c   Cohn, David L ^a,b   Reves, Randall R ^a,b  

^a DENVER PUBLIC HEALTH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Bacteremia; Clarithromycin; DNA fingerprinting; Drug resistance; Mycobacterium avium complex

Indexed keywords

BACTERIAL DNA; CLARITHROMYCIN; CLOFAZIMINE; ETHAMBUTOL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BLOOD CULTURE; DNA FINGERPRINTING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032581456     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199811000-00012     Document Type: Article

References (25)

1. Shafran SD, Singer J, Zarowny DP, et al.: A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996, 335:377-383.
2. Chaisson RE, Keiser P, Pierce M, et al.: Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. AIDS 1997, 11:311-317.
3. May T, Brel F, Beuscart C, et al.: Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. Clin Infect Dis 1997, 25:621-629
4. Dube MP, Sattler FR, Torriani FJ, et al.: A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. J Infect Dis 1997, 176:1225-1232.
5. Burman WJ, Reves RR, Rietmeijer CA, Cohn DL: A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements. Int J Tuberc Lung Dis 1997, 1:163-169.
6. Jarboe E, Stone BL, Burman WJ, Wallace Jr RJ, Reves RR, Wilson ML: Evaluation of a disk-diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin. Diag Microbiol Infect Dis 1998, 30:197-203.
7. Arbeit RD, Slutsky TW, Barber TW, et al.: Genetic diversity among strain of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J Infect Dis 1993, 167:1384-1390.
8. Kemper CA, Havlir D, Haghighat D, et al.: The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS. J Infect Dis 1994, 170:157-164.
9. Bermudez LE, Nash KA, Petrovsky M, Young LS, Inderlied CB: Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. J Infect Dis 1996, 174:1218-1222.
10. Lounis N, Ji B, Truffot-Pernot C, Grosset J: Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse. Antimicrob Agents Chemother 1995, 39:608-612.
11. Gordon SM, Horsburgh Jr CR, Peloquin CA, et al.: Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. J Infect Dis 1993, 168:1559-1562.
12. Cohn D, Fisher E, Franchino B, et al.: A prospective, randomized trial of four 3-drug regimens for treatment of disseminated MAC disease in AIDS: excess mortality associated with high-dose clarithromycin. Fourth Conference on Retroviruses and Opportunistic Infections. Washington, January 1997 [abstract 659].
13. Torriani FJ, McCutchan JA, Maslow JN, Arbeit RD, Havlir DV. Clarithromycin susceptibilities and genetic patterns of Mycobacterium avium complex isolates of patients at autopsy. Third Conference on Retroviruses and Opportunistic Infections. Washington, January 1996 [abstract 207].
14. Chaisson RE, Benson CA, Dube MP, et al.: Clarithromycin therapy for bacteremic Mycobacterium avium complex disease: a randomized, double-blind, dose-ranging study in patients with AIDS. Ann Intern Med 1994, 121:905-911.
15. Palella Jr F, Delany K, Moorman A, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998, 338:853-860.
16. Peloquin C, Nitta C, Burman WJ, et al.: Incidence of low tuberculosis drug concentrations in patients with AIDS. Ann Pharmacother 1996, 30:919-925.
17. Mushlin AI, Appel FA: Diagnosing potential noncompliance: physicians' ability in a behavioral dimension of medical care. Arch Intern Med 1977, 137:318-321.
18. Ormerod LP, Prescott RJ: Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med 1991, 85:239-242.
19. Weis SE, Slocum PC, Blais FX, et al.: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl Med 1994, 330:1179-1184.
20. Torriani FJ, Dube M, Sattler F, et al.: A longitudinal analysis of clarithromycin susceptibilities and genotypes of Mycobacterium avium complex (MAC) isolates of AIDS patients treated for MAC bacteremia. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September, 1995 [abstract 1163].
21. Nash KA, Inderlied CB: Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995, 39:2625-2630.
22. von Reyn CF, Jacobs NJ, Arbeit RD, Maslow JN, Niemczyk S: Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J Clin Microbiol 1995, 33:1008-1010.
23. Slutsky AM, Arbeit RD, Barber TW, et al.: Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential isolates. J Clin Microbiol 1994, 32:1773-1778
24. von Reyn FC, Maslow JN, Barber TW, Falkinham JO, Arbeit RD: Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994, 343:1137-1141.
25. Yajko DM, Chin DP, Gonzalez PC, et al.: Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:176-182.